South Korea CRISPR-Based Therapeutics Market was valued at USD 0.2 Billion in 2022 and is projected to reach USD 1.0 Billion by 2030, growing at a CAGR of 23.0% from 2024 to 2030.
The South Korea CRISPR-Based Therapeutics Market has been gaining significant attention, with its potential to revolutionize medical treatments and genetic research. CRISPR, a powerful tool for gene editing, has opened new doors for therapies aimed at curing genetic disorders, cancer, and other diseases. As the global interest in gene editing grows, South Korea has become a key player in the CRISPR-based therapeutics sector, leveraging its advanced healthcare infrastructure, robust research ecosystem, and supportive government policies.
In South Korea, the demand for CRISPR-based therapies is rapidly expanding due to the growing prevalence of genetic disorders and the country's commitment to biotechnological advancements. The market has seen increased investment from both public and private sectors, aiming to harness CRISPR's potential for precision medicine. This shift has been largely driven by the country’s strong focus on biotech innovation and its desire to be at the forefront of global scientific breakthroughs.
For industries operating in the South Korean CRISPR-based therapeutics market, the requirements are diverse. Pharmaceutical companies and research institutions are particularly focused on enhancing the efficiency and precision of CRISPR tools to ensure safety and reliability in treatments. As a result, there is a strong demand for state-of-the-art gene-editing technology, specialized training for researchers, and regulatory frameworks that ensure ethical applications of CRISPR technology.
Moreover, South Korea’s health industry is keen on addressing regulatory challenges and ensuring the public’s trust in gene-editing procedures. Clinical trials, ethical considerations, and government oversight play a pivotal role in shaping the landscape of CRISPR-based therapies. As such, industries are pushing for collaborative efforts between academia, industry, and regulatory bodies to streamline the development and application of CRISPR therapies in real-world settings.
The South Korea CRISPR-Based Therapeutics Market is also influenced by global collaborations, as local companies partner with international research entities to share knowledge, resources, and innovations. The exchange of information and technology is vital for improving CRISPR-based therapies and advancing the field, not just within South Korea, but on a global scale.
As demand for CRISPR therapies grows, industries in South Korea are increasingly focusing on developing cutting-edge solutions that offer effective treatments for previously untreatable conditions. This trend highlights the country’s potential to lead the way in gene-editing advancements, ensuring a bright future for CRISPR-based therapeutics both locally and globally.
Get an In-Depth Research Analysis of the South Korea CRISPR-Based Therapeutics Market Size And Forecast [2025-2032]
Â
Caribou Biosciences
Addgene
CRISPR THERAPEUTICS
Merck KGaA
Mirus Bio LLC
Editas Medicine
Takara Bio USA
Thermo Fisher Scientific
Horizon Discovery Group
Intellia Therapeutics
GE Healthcare Dharmacon
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the South Korea CRISPR-Based Therapeutics Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the South Korea CRISPR-Based Therapeutics Market
CRISPR-Cas9
CRISPR-Cas12 (Cpf1)
CRISPR-Cas13 (Cpf1)
Others
Oncology
Genetic Disorders
Infectious Diseases
Transplantation
Other Applications
Preclinical
Clinical Trials
Commercialized Products
Viral Vectors
Electroporation
Microinjection
Other Delivery Methods
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
CROs (Contract Research Organizations)
Others
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
For More Information or Query, Visit @ South Korea CRISPR-Based Therapeutics Market Research Analysis
1. Introduction of the South Korea CRISPR-Based Therapeutics Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. South Korea CRISPR-Based Therapeutics Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. South Korea CRISPR-Based Therapeutics Market, By Type
6. South Korea CRISPR-Based Therapeutics Market, By Application
7. South Korea CRISPR-Based Therapeutics Market, By Geography
Asia-Pacific
China
Japan
Korea
India
Australia
Indonesia
Thailand
Philippines
Malaysia and Vietnam
8. South Korea CRISPR-Based Therapeutics Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/